What if cancer isn’t primarily a genetic disease but a metabolic one?In this episode, Ben sits down with radiation oncologist Dr. Kristy Kessling to explore a radically different lens on cancer, one that centers on mitochondria, insulin resistance, inflammation, and the internal “terrain” of the body.Dr. Kessling explains why she believes cancer begins with mitochondrial stress not random bad luck and why insulin and IGF-1 may be more important drivers than most patients are ever told. We unpack the difference between attacking cancer cells and improving the body’s metabolic environment, and why those two approaches are not the same.Topics covered:Why “cancer is a metabolic disease” is more than just a sloganThe role of insulin, IGF-1, and glucose in tumour growthBRCA genes: why genes are not destinyThe three biomarkers Dr. Kessling prioritizes for prevention and recurrenceKetogenic and carnivore diets, what matters, and common mistakesFasting and ketosis alongside chemotherapy (and why some patients experience fewer side effects)Cancer stem cells and the importance of terrainWhy recurrence prevention mirrors prevention itselfThe overlooked role of stress, mindset, and emotional healthThis conversation challenges the conventional narrative and offers something deeply empowering the idea that metabolic health gives us more agency than we’ve been led to believe.Whether you’re navigating a diagnosis, focused on prevention, or simply interested in the intersection of metabolism and chronic disease, this episode offers a hopeful and thought-provoking perspective.Exploring the benefits of red and infra light therapy? Our community receive 10% off via this linkWant to watch this on video? Subscribe on YouTubeInstagram @degreesofhealthDisclaimer Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related